3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
13
Lung Neoplasms
7
Multiple Myeloma
2
Lymphoma
2
Hematologic Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Solid Tumor
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder)
1
Neoplasms
1
Melanoma
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
durvalumab
3
abemaciclib
2
Pemetrexed
2
Fulvestrant
2
Cisplatin
2
Carboplatin
2
ribociclib
1
repotrectinib
1
pembrolizumab
1
palbociclib
1
exemestane
1
elacestrant
1
cemiplimab
1
atezolizumab
1
Tamoxifen
1
STX-478
1
RAD1901
1
Nivolumab
1
Metformin
1
Letrozole
1
Immunotherapy
1
Imlunestrant
1
Drug Therapy
1
Docetaxel
1
Bevacizumab
1
Anastrozole
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms by Site
×
osimertinib
×
30 days
×
Clear all
No trials found.